Tapewire

NYSE · USD

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Export transactions ↓
Tapewire entity
3398
SEC CIK
0001100682
Parsed reports
686

Last 12 months

Inside the activity.

2 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 2026017
Sep 202610
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 27, 2022 Filed Jun 1, 2022 21:15 UTC
Pease FlaviaCorporate Executive VP & CFO
GrantCommon Stock 1,637 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-016211 · form4.xml · nonDerivative · entry 1

Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,822

F1 · shares: Unvested restricted stock units vest as follows: 409 on May 27, 2023, 409 on May 27, 2024, 409 on May 27, 2025 and 410 on May 27, 2026.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 21:14 UTC
Barbo William DCorporate Executive VP & CCO
GrantStock Options (Right to Buy) · Derivative 4,036 $244.41 Strike: $244.41 $986,438.76
Disclosure

SEC source: 0001127602-22-016208 · form4.xml · derivative · entry 6

Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,036

Underlying: Common Stock · 4,036 shares

Expires 2032-05-27

F2 · shares: Stock Options vest as follows: 1,009 on May 27, 2023, 1,009 on May 27, 2024, 1,009 on May 27, 2025 and 1,009 on May 27, 2026.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 21:14 UTC
Barbo William DCorporate Executive VP & CCO
GrantCommon Stock 1,493 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-016208 · form4.xml · nonDerivative · entry 3

Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,508

F1 · shares: Unvested restricted stock units vest as follows: 373 on May 27, 2023, 373 on May 27, 2024, 373 on May 27, 2025 and 374 on May 27, 2026.

Read SEC document
May 11, 2022 Filed May 13, 2022 16:41 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014444 · form4.xml · derivative · entry 3

REESE C RICHARD · CIK 0001032365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F3 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 16:41 UTC GrantCommon Stock 382 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014444 · form4.xml · nonDerivative · entry 2

REESE C RICHARD · CIK 0001032365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,435

F2 · shares: The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 16:41 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014444 · form4.xml · nonDerivative · entry 1

REESE C RICHARD · CIK 0001032365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,053

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:57 UTC GrantStock Options (Right to Buy) · Derivative 1,512 $222.31 Strike: $222.31 $336,132.72
Disclosure

SEC source: 0001127602-22-014473 · form4.xml · derivative · entry 3

MACKAY MARTIN · CIK 0001414815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,512

Underlying: Common Stock · 1,512 shares

Expires 2032-05-11

F3 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:57 UTC GrantCommon Stock 292 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014473 · form4.xml · nonDerivative · entry 2

MACKAY MARTIN · CIK 0001414815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,503

F2 · shares: The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:57 UTC GrantCommon Stock 549 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014473 · form4.xml · nonDerivative · entry 1

MACKAY MARTIN · CIK 0001414815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,211

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:50 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014461 · form4.xml · derivative · entry 2

WILSON VIRGINIA M · CIK 0001262696 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F2 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:50 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014461 · form4.xml · nonDerivative · entry 1

WILSON VIRGINIA M · CIK 0001262696 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,742

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:44 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014452 · form4.xml · derivative · entry 4

WALLMAN RICHARD F · CIK 0001198092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F3 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:44 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014452 · form4.xml · nonDerivative · entry 2

WALLMAN RICHARD F · CIK 0001198092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,614

F2 · shares: The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:44 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014452 · form4.xml · nonDerivative · entry 1

WALLMAN RICHARD F · CIK 0001198092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,254

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:36 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014431 · form4.xml · derivative · entry 2

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F2 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:36 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014431 · form4.xml · nonDerivative · entry 1

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,252

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:24 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014411 · form4.xml · derivative · entry 3

Llado George Sr. · CIK 0001829162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F3 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:24 UTC GrantCommon Stock 292 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014411 · form4.xml · nonDerivative · entry 2

Llado George Sr. · CIK 0001829162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,820

F2 · shares: The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:24 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014411 · form4.xml · nonDerivative · entry 1

Llado George Sr. · CIK 0001829162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,528

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:20 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014408 · form4.xml · derivative · entry 2

Kochevar Deborah Turner · CIK 0001448579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F2 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:20 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014408 · form4.xml · nonDerivative · entry 1

Kochevar Deborah Turner · CIK 0001448579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,671

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:11 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014401 · form4.xml · derivative · entry 3

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2032-05-11

F3 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:11 UTC GrantCommon Stock 405 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014401 · form4.xml · nonDerivative · entry 2

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,717

F2 · shares: The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:11 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014401 · form4.xml · nonDerivative · entry 1

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,312

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:03 UTC GrantStock Options (Right to Buy) · Derivative 1,582 $222.31 Strike: $222.31 $351,694.42
Disclosure

SEC source: 0001127602-22-014388 · form4.xml · derivative · entry 2

Andrews Nancy C · CIK 0001804999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,582

Underlying: Common Stock · 1,582 shares

Expires 2022-05-12

F2 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:03 UTC GrantCommon Stock 575 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014388 · form4.xml · nonDerivative · entry 1

Andrews Nancy C · CIK 0001804999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,795

F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 8 $238.06 $1,904.48
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 7

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,677

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 15 $235.23 $3,528.45
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 6

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,685

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 13 $232.79 $3,026.27
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 5

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,700

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 15 $231.88 $3,478.20
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 4

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,713

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 15 $230.33 $3,454.95
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 3

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,728

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 88 $229.90 $20,230.95
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 2

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,743

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $229.43 to $230.045. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 09, 2022 Filed May 11, 2022 19:52 UTC SaleCommon Stock 24 $228.62 $5,486.88
Disclosure

SEC source: 0001127602-22-014132 · form4.xml · nonDerivative · entry 1

MASSARO GEORGE · CIK 0001221496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,831

F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $228.22 to $228.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 02, 2022 Filed May 4, 2022 20:38 UTC
Pease FlaviaCorporate Executive VP
GrantStock Options (Right to Buy) · Derivative 4,649 $245.88 Strike: $245.88 $1,143,096.12
Disclosure

SEC source: 0001127602-22-013202 · form4.xml · derivative · entry 2

Pease Flavia · CIK 0001924996 · Corporate Executive VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,649

Underlying: Common Stock · 4,649 shares

Expires 2032-05-02

F2 · shares: Stock Options vest as follows: 2,324 on May 02, 2024, and 2,325 on May 02, 2025.

Read SEC document
May 02, 2022 Filed May 4, 2022 20:38 UTC
Pease FlaviaCorporate Executive VP
GrantCommon Stock 5,185 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-013202 · form4.xml · nonDerivative · entry 1

Pease Flavia · CIK 0001924996 · Corporate Executive VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,185

F1 · shares: Unvested restricted stock units vest as follows: 2,592 on May 02, 2024, and 2,593 on May 02, 2025.

Read SEC document
March 11, 2022 Filed Jun 1, 2022 21:14 UTC
Barbo William DCorporate Executive VP & CCO
GiftCommon Stock 754 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-016208 · form4.xml · nonDerivative · entry 2

Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 18,844

Read SEC document
March 11, 2022 Filed Jun 1, 2022 21:14 UTC
Barbo William DCorporate Executive VP & CCO
GiftCommon Stock 754 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-016208 · form4.xml · nonDerivative · entry 1

Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,015

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
Exercise / conversionStock Options (Right to Buy) · Derivative 1,815 $0.00 Strike: $179.66 $0.00
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · derivative · entry 11

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,446

Underlying: Common Stock · 1,815 shares

Expires 2030-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
Exercise / conversionStock Options (Right to Buy) · Derivative 3,304 $0.00 Strike: $144.67 $0.00
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · derivative · entry 10

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,305

Underlying: Common Stock · 3,304 shares

Expires 2024-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
Exercise / conversionStock Options (Right to Buy) · Derivative 3,846 $0.00 Strike: $109.34 $0.00
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · derivative · entry 9

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,846 shares

Expires 2023-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
SaleCommon Stock 387 $285.16 $110,356.65
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 8

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,819

F5 · price: This transaction was executed in multiple trades at prices ranging from $285.09 to $285.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
SaleCommon Stock 858 $284.58 $244,170.84
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 7

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,206

F4 · price: This transaction was executed in multiple trades at prices ranging from $284.28 to $284.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
SaleCommon Stock 1,289 $283.41 $365,316.26
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 6

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,064

F3 · price: This transaction was executed in multiple trades at prices ranging from $283.00 to $283.7. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
SaleCommon Stock 2,606 $282.56 $736,360.74
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 5

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,353

F2 · price: This transaction was executed in multiple trades at prices ranging from $281.98 to $282.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
SaleCommon Stock 3,825 $281.49 $1,076,716.08
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 4

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,959

F1 · price: This transaction was executed in multiple trades at prices ranging from $280.98 to $281.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
Exercise / conversionCommon Stock 1,815 $179.66 $326,082.90
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 3

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
Exercise / conversionCommon Stock 3,304 $144.67 $477,989.68
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 2

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,969

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:13 UTC
Smith David RossCorporate Executive VP & CFO
Exercise / conversionCommon Stock 3,846 $109.34 $420,521.64
Disclosure

SEC source: 0001127602-22-008258 · form4.xml · nonDerivative · entry 1

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 22:33 UTC
Smith David RossCorporate Executive VP & CFO
GrantCommon Stock 5,152 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007805 · form4.xml · nonDerivative · entry 1

Smith David Ross · CIK 0001650274 · Corporate Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,819

F1 · shares: Unvested restricted stock units vest as follows: 5,152 on February 28, 2023.

Read SEC document
February 23, 2022 Filed Feb 23, 2022 21:49 UTC
FOSTER JAMES CDirector · Chairman, President and CEO
Tax withholdingCommon Stock 1,770 $289.58 $512,556.60
Disclosure

SEC source: 0001127602-22-006351 · form4.xml · nonDerivative · entry 11

FOSTER JAMES C · CIK 0001141722 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,022

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.